These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35743167)

  • 21. Epigenetic silencing of the oncogenic miR-17-92 cluster during PU.1-directed macrophage differentiation.
    Pospisil V; Vargova K; Kokavec J; Rybarova J; Savvulidi F; Jonasova A; Necas E; Zavadil J; Laslo P; Stopka T
    EMBO J; 2011 Sep; 30(21):4450-64. PubMed ID: 21897363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The tumor suppressor gene DAPK2 is induced by the myeloid transcription factors PU.1 and C/EBPα during granulocytic differentiation but repressed by PML-RARα in APL.
    Humbert M; Federzoni EA; Britschgi A; Schläfli AM; Valk PJ; Kaufmann T; Haferlach T; Behre G; Simon HU; Torbett BE; Fey MF; Tschan MP
    J Leukoc Biol; 2014 Jan; 95(1):83-93. PubMed ID: 24038216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation.
    Rosa A; Ballarino M; Sorrentino A; Sthandier O; De Angelis FG; Marchioni M; Masella B; Guarini A; Fatica A; Peschle C; Bozzoni I
    Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19849-54. PubMed ID: 18056638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ski can negatively regulates macrophage differentiation through its interaction with PU.1.
    Ueki N; Zhang L; Hayman MJ
    Oncogene; 2008 Jan; 27(3):300-7. PubMed ID: 17621263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kras mutations and PU.1 promoter methylation are new pathways in murine radiation-induced AML.
    O'Brien G; Cruz-Garcia L; Zyla J; Brown N; Finnon R; Polanska J; Badie C
    Carcinogenesis; 2020 Aug; 41(8):1104-1112. PubMed ID: 31646336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Runx-PU.1 pathway preserves normal and AML/ETO9a leukemic stem cells.
    Staber PB; Zhang P; Ye M; Welner RS; Levantini E; Di Ruscio A; Ebralidze AK; Bach C; Zhang H; Zhang J; Vanura K; Delwel R; Yang H; Huang G; Tenen DG
    Blood; 2014 Oct; 124(15):2391-9. PubMed ID: 25185713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CITED2-mediated human hematopoietic stem cell maintenance is critical for acute myeloid leukemia.
    Korthuis PM; Berger G; Bakker B; Rozenveld-Geugien M; Jaques J; de Haan G; Schuringa JJ; Vellenga E; Schepers H
    Leukemia; 2015 Mar; 29(3):625-35. PubMed ID: 25184385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PU.1 and CEBPA expression in acute myeloid leukemia.
    D'Alò F; Di Ruscio A; Guidi F; Fabiani E; Greco M; Rumi C; Hohaus S; Voso MT; Leone G
    Leuk Res; 2008 Sep; 32(9):1448-53. PubMed ID: 18308386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A distal single nucleotide polymorphism alters long-range regulation of the PU.1 gene in acute myeloid leukemia.
    Steidl U; Steidl C; Ebralidze A; Chapuy B; Han HJ; Will B; Rosenbauer F; Becker A; Wagner K; Koschmieder S; Kobayashi S; Costa DB; Schulz T; O'Brien KB; Verhaak RG; Delwel R; Haase D; Trümper L; Krauter J; Kohwi-Shigematsu T; Griesinger F; Tenen DG
    J Clin Invest; 2007 Sep; 117(9):2611-20. PubMed ID: 17694175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The natural anti-tumor compound Celastrol targets a Myb-C/EBPβ-p300 transcriptional module implicated in myeloid gene expression.
    Coulibaly A; Haas A; Steinmann S; Jakobs A; Schmidt TJ; Klempnauer KH
    PLoS One; 2018; 13(2):e0190934. PubMed ID: 29394256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional regulators CITED2 and PU.1 cooperate in maintaining hematopoietic stem cells.
    Mattes K; Geugien M; Korthuis PM; Brouwers-Vos AZ; Fehrmann RSN; Todorova TI; Steidl U; Vellenga E; Schepers H
    Exp Hematol; 2019 May; 73():38-49.e7. PubMed ID: 30986495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Down-regulation of transcription factor PU.1 via abnormal epigenetic modification in chronic myeloid leukemia].
    Yang H; Yan JS; Tao R; Hao SG; Liang H; Ma LY
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):169-75. PubMed ID: 22780968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PU.1-Regulated Long Noncoding RNA lnc-MC Controls Human Monocyte/Macrophage Differentiation through Interaction with MicroRNA 199a-5p.
    Chen MT; Lin HS; Shen C; Ma YN; Wang F; Zhao HL; Yu J; Zhang JW
    Mol Cell Biol; 2015 Sep; 35(18):3212-24. PubMed ID: 26149389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of c-myc gene accompanied by PU.1 deficiency in radiation-induced acute myeloid leukemia in mice.
    Hirouchi T; Takabatake T; Yoshida K; Nitta Y; Nakamura M; Tanaka S; Ichinohe K; Oghiso Y; Tanaka K
    Exp Hematol; 2008 Jul; 36(7):871-85. PubMed ID: 18375040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological inhibition of the transcription factor PU.1 in leukemia.
    Antony-Debré I; Paul A; Leite J; Mitchell K; Kim HM; Carvajal LA; Todorova TI; Huang K; Kumar A; Farahat AA; Bartholdy B; Narayanagari SR; Chen J; Ambesi-Impiombato A; Ferrando AA; Mantzaris I; Gavathiotis E; Verma A; Will B; Boykin DW; Wilson WD; Poon GM; Steidl U
    J Clin Invest; 2017 Dec; 127(12):4297-4313. PubMed ID: 29083320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
    Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
    Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coordination of Myeloid Differentiation with Reduced Cell Cycle Progression by PU.1 Induction of MicroRNAs Targeting Cell Cycle Regulators and Lipid Anabolism.
    Solomon LA; Podder S; He J; Jackson-Chornenki NL; Gibson K; Ziliotto RG; Rhee J; DeKoter RP
    Mol Cell Biol; 2017 May; 37(10):. PubMed ID: 28223367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distal regulation of c-myb expression during IL-6-induced differentiation in murine myeloid progenitor M1 cells.
    Zhang J; Han B; Li X; Bies J; Jiang P; Koller RP; Wolff L
    Cell Death Dis; 2016 Sep; 7(9):e2364. PubMed ID: 27607579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PU.1-Dependent Enhancer Inhibition Separates Tet2-Deficient Hematopoiesis from Malignant Transformation.
    Aivalioti MM; Bartholdy BA; Pradhan K; Bhagat TD; Zintiridou A; Jeong JJ; Thiruthuvanathan VJ; Pujato M; Paranjpe A; Zhang C; Levine RL; Viny AD; Wickrema A; Verma A; Will B
    Blood Cancer Discov; 2022 Sep; 3(5):444-467. PubMed ID: 35820129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal autoregulation during human PU.1 locus SubTAD formation.
    Schuetzmann D; Walter C; van Riel B; Kruse S; König T; Erdmann T; Tönges A; Bindels E; Weilemann A; Gebhard C; Wethmar K; Perrod C; Minderjahn J; Rehli M; Delwel R; Lenz G; Gröschel S; Dugas M; Rosenbauer F
    Blood; 2018 Dec; 132(25):2643-2655. PubMed ID: 30315124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.